JBC Biosymposia, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M409811200 on January 18, 2005

J. Biol. Chem., Vol. 280, Issue 14, 13538-13544, April 8, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/14/13538    most recent
M409811200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paruchuri, S.
Right arrow Articles by Sjölander, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paruchuri, S.
Right arrow Articles by Sjölander, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Pro-inflammatory Mediator Leukotriene D4 Induces Phosphatidylinositol 3-Kinase and Rac-dependent Migration of Intestinal Epithelial Cells*

Sailaja Paruchuri, Oliver Broom, Karim Dib, and Anita Sjölander{ddagger}

From the Experimental Pathology, Department of Laboratory Medicine, Lund University, University Hospital Malmö, SE-205 02 Malmö, Sweden

Inflammatory bowel diseases are associated with increased risk of developing colon cancer. A possible role of the pro-inflammatory leukotriene D4 (LTD4) in this process has been implicated by the findings that LTD4 can signal increased proliferation and survival, both hallmarks of a cancer cell, in non-transformed intestinal epithelial cells. Here we make the novel finding that LTD4 can also signal increased motility in these cells. In parallel, we found that LTD4 induced a simultaneous transient 10-fold increase in Rac but not Cdc42 activity. These data were also supported by the ability of LTD4 to activate the Rac GDP/GTP exchange factor Vav2. Further, LTD4 triggered a 3-fold transient increase in phosphatidylinositol 3-kinase (PI3K) phosphorylation, a possible upstream activator of the Vav2/Rac signaling pathway. The activation of Rac was blocked by the PI3K inhibitors LY294002 and wortmannin and by transfection of a kinase-negative mutant of PI3K or a dominant-negative form of Vav2. Furthermore, Rac was found to co-localize with actin in LTD4-generated membrane ruffles that were formed by a PI3K-dependent mechanism. In accordance, the inhibition of the PI3K and Rac signaling pathway also blocked the LTD4-induced migration of the intestinal cells. The present data reveal that an inflammatory mediator such as LTD4 cannot only increase proliferation and survival of non-transformed intestinal epithelial cells but also, via a PI3K/Rac signaling pathway, trigger a motile response in such cells. These data demonstrate the capacity of inflammatory mediators to participate in the process by which inflammatory bowel conditions increase the risk for colon cancer development.


Received for publication, August 26, 2004 , and in revised form, December 29, 2004.

* This work was supported by the grants from the Swedish Cancer Foundation, the Swedish Medical Research Council, the Foundations at Malmö University Hospital, the Ruth and Richard Julins Foundation, Magnus Bergvalls Foundation, Gunnar Nilssons Foundation, and the Österlund Foundation (to A. S.) and from the Royal Physiographic Society in Lund and the Swedish Society for Medical Research (to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Dept. of Laboratory Medicine, Experimental Pathology, Lund University, Malmö University Hospital, Entrance 78, SE-205 02 Malmö, Sweden. Tel.: 46-40-337223; Fax: 46-40-337353; E-mail: anita.sjolander{at}exppat.mas.lu.se.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
B. Sveinbjornsson, A. Rasmuson, N. Baryawno, M. Wan, I. Pettersen, F. Ponthan, A. Orrego, J. Z. Haeggstrom, J. I. Johnsen, and P. Kogner
Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy
FASEB J, October 1, 2008; 22(10): 3525 - 3536.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Jiang, J. L. A. Siggers, H. H.-Y. Ngai, W.-H. Sit, P. T. Sangild, and J. M.-F. Wan
The Small Intestine Proteome Is Changed in Preterm Pigs Developing Necrotizing Enterocolitis in Response to Formula Feeding
J. Nutr., October 1, 2008; 138(10): 1895 - 1901.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Profita, A. Sala, A. Bonanno, L. Siena, M. Ferraro, R. Di Giorgi, A. M. Montalbano, G. D. Albano, R. Gagliardo, and M. Gjomarkaj
Cysteinyl Leukotriene-1 Receptor Activation in a Human Bronchial Epithelial Cell Line Leads to Signal Transducer and Activator of Transcription 1-Mediated Eosinophil Adhesion
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 1024 - 1030.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. A. Babbin, A. J. Jesaitis, A. I. Ivanov, D. Kelly, M. Laukoetter, P. Nava, C. A. Parkos, and A. Nusrat
Formyl Peptide Receptor-1 Activation Enhances Intestinal Epithelial Cell Restitution through Phosphatidylinositol 3-Kinase-Dependent Activation of Rac1 and Cdc42
J. Immunol., December 15, 2007; 179(12): 8112 - 8121.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Magnusson, R. Ehrnstrom, J. Olsen, and A. Sjolander
An Increased Expression of Cysteinyl Leukotriene 2 Receptor in Colorectal Adenocarcinomas Correlates with High Differentiation
Cancer Res., October 1, 2007; 67(19): 9190 - 9198.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Z Wu, K. McRoberts, and D Theodorescu
The role of PTEN in prostate cancer cell tropism to the bone micro-environment
Carcinogenesis, July 1, 2007; 28(7): 1393 - 1400.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Mezhybovska, K. Wikstrom, J. F. Ohd, and A. Sjolander
The Inflammatory Mediator Leukotriene D4 Induces beta-Catenin Signaling and Its Association with Antiapoptotic Bcl-2 in Intestinal Epithelial Cells
J. Biol. Chem., March 10, 2006; 281(10): 6776 - 6784.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.